The continually expanding toolkit from Mohit Verma's laboratory at Purdue University now includes a portable, paper-based ...

The U.S. molecular biology enzymes, reagents, and kits market, valued at USD 5.95 billion in 2024, is expected to grow at a 9.65% CAGR from 2025 to 2033. Rising chronic and infectious diseases, ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. Bio-Rad Laboratories, Inc. ( NYSE: BIO) Wells Fargo 20th Annual Healthcare Conference ...

Azooka Labs, founded by molecular biologist Dr Fathima Benazir and her childhood friend-turned-co-founder Alex D. Paul, is ...

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared the risk-adjusted net present value (rNPV) ...

Resilient transformation, global reach, and pioneering carbon thinking headline Braskem’s presence at the world’s leading ...

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), today shared the risk-adjusted net present value (rNPV) estimate of $9 billion to $11 ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

Metabolic dysfunction-associated steatohepatitis (MASLD) is a liver disease with complex pathogenesis, characterized by ...

According to MarketsandMarkets, The bacteriological testing market is valued at USD 25.83 billion in 2025. It is projected to reach USD 37.26 ...

The authors argue that male-biased expression of Cyp17a2 is implicated in mediating infection levels through STING and USP8 activity regulation. Thus, this study highlights an unexpected factor ...